Home › Compare › NPTVF vs ABBV
NPTVF yields 1.00% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, NPTVF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NPTVF + ABBV for your $10,000?
Nippon Television Holdings, Inc. operates as a media and content company in Japan. The company engages in the production of broadcasting programs; digital broadcasting; technical production related to studios, live broadcasting, master technology, EJ news gathering, editing, postproduction, etc.; and programming, content production, closed captioning, library, etc. It is also involved in sporting and various NTV events; the management of NTV school; art design, and lighting and sound effects; design of sets, flip charts, and TV graphics; production of pamphlets, posters, etc.; intellectual property management; management of music publishing, CD master, and merchandising rights; production CDs and DVDs; rental of recording studios; and operation of fitness clubs, insurance agencies, and museums. In addition, the company engages in the production and construction of exhibitions, sales promotion events, international sports events, theme parks, amusement facilities, national ceremonies, etc.; production of program-related merchandise goods; commercial building maintenance; race track, concerts, and events management; ICT, development of apps for business, web development, video streaming, infrastructure solutions, and advertising; shopping portal sites management; production of animation, TV programs, commercial films, graphic designs, illustrations, characters, social games, and other content; copyright management; and internet content streaming. Further, it engages in the provision of software and systems for VOD and live streaming platforms and players; news gathering, reporting, and production of information, sports programs, etc.; 3D computer graphics; services to program and technology production, clerical, and management duties; e-commerce, esports, and talent production agency businesses; contractual production of programs for broadcasters; and influencers network and production business. The company was incorporated in 1952 and is based in Tokyo, Japan.
Full NPTVF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.